Panagora Asset Management Inc Cytom X Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.53 - $2.89 $13 - $26	9 Added 0.01%	114,014 $209,000
Q1 2022 May 12, 2022	BUY	$2.67 - $4.68 $2,862 - $5,016	1,072 Added 0.95%	114,005 $304,000
Q4 2021 Feb 10, 2022	BUY	$3.87 - $7.39 $452 - $864	117 Added 0.1%	112,933 $489,000
Q3 2021 Nov 10, 2021	BUY	$4.32 - $6.43 $82,611 - $122,960	19,123 Added 20.41%	112,816 $574,000
Q2 2021 Aug 11, 2021	BUY	$6.33 - $9.91 $449,430 - $703,610	71,000 Added 312.87%	93,693 $593,000
Q1 2021 May 12, 2021	SELL	$6.6 - $9.0 $500,200 - $682,092	-75,788 Reduced 76.96%	22,693 $175,000
Q4 2020 Feb 10, 2021	SELL	$6.47 - $7.9 $1.12 Million - $1.37 Million	-173,252 Reduced 63.76%	98,481 $645,000
Q3 2020 Nov 13, 2020	SELL	$6.55 - $8.83 $582,078 - $784,695	-88,867 Reduced 24.64%	271,733 $1.81 Million
Q2 2020 Aug 12, 2020	BUY	$7.4 - $14.64 $59,318 - $117,354	8,016 Added 2.27%	360,600 $3 Million
Q1 2020 May 14, 2020	SELL	$3.61 - $8.6 $469,130 - $1.12 Million	-129,953 Reduced 26.93%	352,584 $2.7 Million
Q4 2019 Feb 12, 2020	BUY	$5.17 - $8.91 $2.49 Million - $4.3 Million	482,537 New	482,537 $4.01 Million
Q2 2019 Aug 09, 2019	SELL	$9.35 - $11.41 $609,236 - $743,464	-65,159 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $222,024 - $447,788	-23,371 Reduced 26.4%	65,159 $700,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $1.16 Million - $1.71 Million	-91,709 Reduced 50.88%	88,530 $1.34 Million
Q3 2018 Nov 13, 2018	SELL	$18.04 - $26.41 $640,582 - $937,792	-35,509 Reduced 16.46%	180,239 $3.33 Million
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $1.21 Million - $1.68 Million	56,734 Added 35.68%	215,748 $4.93 Million
Q1 2018 May 15, 2018	SELL	$21.76 - $34.22 $623,271 - $980,163	-28,643 Reduced 15.26%	159,014 $4.52 Million
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $1.17 Million - $1.43 Million	61,767 Added 49.06%	187,657 $3.96 Million
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $1.7 Million - $2.29 Million	125,890	125,890 $2.29 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

49.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$6.56 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$4.39 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$4.34 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.04 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$2.6 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account